Investigation of the Role of microRNA Associated with the VHL-HIFα-Dependent Pathway in Patients with Clear Cell Renal Cell Carcinoma

被引：0
|
作者：
E. A. Klimentova
I. R. Gilyazova
M. A. Bermisheva
A. M. Blinnikova
R. I. Safiullin
A. A. Izmailov
B. Yang
V. N. Pavlov
E. K. Khusnutdinova
机构：
[1] Institute of Biochemistry and Genetics,
[2] Ufa Federal Research Centre,undefined
[3] Russian Academy of Sciences,undefined
[4] Bashkir State Medical University,undefined
[5] Harbin Medical University,undefined
来源：
Russian Journal of Genetics | 2020年 / 56卷
关键词：
renal cell carcinoma; miRNA; gene expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：363 / 369
页数：6
相关论文
共 50 条
  • [1] Investigation of the Role of microRNA Associated with the VHL-HIFα-Dependent Pathway in Patients with Clear Cell Renal Cell Carcinoma
    Klimentova, E. A.
    Gilyazova, I. R.
    Bermisheva, M. A.
    Blinnikova, A. M.
    Safiullin, R., I
    Izmailov, A. A.
    Yang, B.
    Pavlov, V. N.
    Khusnutdinova, E. K.
    RUSSIAN JOURNAL OF GENETICS, 2020, 56 (03) : 363 - 369
  • [2] MicroRNA Target Site Polymorphisms in the VHL-HIF1α Pathway Predict Renal Cell Carcinoma Risk
    Wei, Hua
    Ke, Hung-Lung
    Lin, Jie
    Shete, Sanjay
    Wood, Christopher G.
    Hildebrandt, Michelle A. T.
    MOLECULAR CARCINOGENESIS, 2014, 53 (01) : 1 - 7
  • [3] TET2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF Signaling
    Zhang, Xinchao
    Li, Shuyan
    He, Jing
    Jin, Yunjie
    Zhang, Ruonan
    Dong, Wenjing
    Lin, Mingen
    Yang, Yajing
    Tian, Tongguan
    Zhou, Yuefan
    Xu, Yixin
    Lei, Qun-Ying
    Zhang, Jing
    Zhang, Qing
    Xu, Yanping
    Lv, Lei
    CANCER RESEARCH, 2022, 82 (11) : 2097 - 2109
  • [4] The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma
    Qin, C.
    Cao, Q.
    Ju, X.
    Wang, M.
    Meng, X.
    Zhu, J.
    Yan, F.
    Li, P.
    Ding, Q.
    Chen, J.
    Gu, M.
    Zhang, W.
    Yin, C.
    Zhang, Z.
    ANNALS OF ONCOLOGY, 2012, 23 (04) : 981 - 989
  • [5] Evolution of the HIF targeted therapy in clear cell renal cell carcinoma
    Golijanin, Borivoj
    Malshy, Kamil
    Khaleel, Sari
    Lagos, Galina
    Amin, Ali
    Cheng, Liang
    Golijanin, Dragan
    Mega, Anthony
    CANCER TREATMENT REVIEWS, 2023, 121
  • [6] VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma
    Yao, Xiaosai
    Tan, Jing
    Lim, Kevin Junliang
    Koh, Joanna
    Ooi, Wen Fong
    Li, Zhimei
    Huang, Dachuan
    Xing, Manjie
    Chan, Yang Sun
    Qu, James Zhengzhong
    Tay, Su Ting
    Wijaya, Giovani
    Lam, Yue Ning
    Hong, Jing Han
    Lee-Lim, Ai Ping
    Guan, Peiyong
    Ng, Michelle Shu Wen
    He, Cassandra Zhengxuan
    Lin, Joyce Suling
    Nandi, Tannistha
    Qamra, Aditi
    Xu, Chang
    Myint, Swe Swe
    Davies, James O. J.
    Goh, Jian Yuan
    Loh, Gary
    Tan, Bryan C.
    Rozen, Steven G.
    Yu, Qiang
    Tan, Iain Bee Huat
    Cheng, Christopher Wai Sam
    Li, Shang
    Chang, Kenneth Tou En
    Tan, Puay Hoon
    Silver, David Lawrence
    Lezhava, Alexander
    Steger, Gertrud
    Hughes, Jim R.
    Teh, Bin Tean
    Tan, Patrick
    CANCER DISCOVERY, 2017, 7 (11) : 1284 - 1305
  • [7] MicroRNA Signatures in Clear Cell Renal Cell Carcinoma: Exploring Potential Implications for Prognosis
    Zhang, Minghui
    Christensen, Brock
    Salas, Lucas
    ONCOLOGIST, 2024, 29 : S29 - S30
  • [8] MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma
    Nofech-Mozes, Roy
    Khella, Heba W. Z.
    Scorilas, Andreas
    Youssef, Leza
    Krylov, Sergey N.
    Lianidou, Evi
    Sidiropoulos, Konstantinos G.
    Gabril, Manal
    Evans, Andrew
    Yousef, George M.
    CANCER MEDICINE, 2016, 5 (04): : 656 - 664
  • [9] Identification of microRNA editing sites in clear cell renal cell carcinoma
    Liu, Yulong
    Guo, Shiyong
    Xie, Wenping
    Yang, Huaide
    Li, Wanran
    Zhou, Nan
    Yang, Jun
    Zhou, Guangchen
    Mao, Chunyi
    Zheng, Yun
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [10] Targeting HIF-2α: the role of belzutifan in clear cell renal carcinoma management
    Valdes, Alejandro
    Pizarro, Gonzalo
    Gonzalez-Montero, Jaime
    Rojas, Carlos
    Burotto, Mauricio
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2025, 18 (1-2) : 17 - 27
12345